KEY NOTE: Driving CRO Performance in Clinical Trials

  • Determining the optimal stage for CRO engagement to maximize efficiency
  • Engaging CROs in protocol development to inform strategic decisions, including country selection and trial design considerations
  • Leveraging CRO expertise by fostering a collaborative, partnership-driven relationship

Speaker Hosted Roundtables

Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

Roundtable session lasts for 30 minutes and rotate

ROUNDTABLE 1: Optimized clinical development strategies and milestone planning for the enablement of long-term strategic partnerships

Hyojin Park, Business Development Manager, GlobalData Healthcare

ROUNDTABLE 2: Driving Efficiency and Results Through Strong Sponsor, CRO Partnerships

YongGwan Kim, Associate Director, Janssen

ROUNDTABLE 3: Comparator Sourcing in Small Biotech: Overcoming Limits with Strategic Outsourcing

ROUNDTABLE 4: Integrating Packaging and Labeling with Clinical Supply Chain Operations

Keynote Presentation – Inside the Inbox: Real Attacks Hitting Financial Services in 2025

Attackers are bypassing legacy tools with business email compromise (BEC), account takeover (ATO), QR code phishing, and OAuth consent scams at increasing scale. We will share anonymized, recent cases from financial services environments, including how a global firm saw advanced attacks bypass a traditional secure email gateway and what actually stopped them. Co-presented by Abnormal AI and BlueFort, attendees leave with a practical playbook: the signals to look for, the controls that work, and how to achieve time-to-value without added friction.

Breakfast Deep-Dive: Greenwashing or Planet-Proofing

Authenticity, transparency, and verifiability of environmental claims

  • How are brands using marketing to appear sustainable?
  • Do consumers “talk the talk” but not “walk the walk”?
  • Genuine planet-proofing: Ensuring verifiable actions that reduce environmental harm across the product’s entire life cycle
  • What is the commitment of businesses to ESG?

Join this expert-led, peer-to-peer deep-dive session to hear from those in the know. Take back to your business an understanding of what it takes to succeed and lessons learned from those who have been there, done that.

Delegates must pre-register interest prior to the day of the event.

Leveraging Advanced Technology to Drive Efficiency, Resilience, and Customer Value in Uncertain Times

  • Showcasing Siemens Financial Services’ global footprint and strategic role in enabling
    technology-driven financing solutions across industries
  • Exploring how advanced technologies—especially AI—boost efficiency and customer
    engagement, creating measurable value in volatile and uncertain market conditions
  • Presenting practical use cases of Everyday AI and Process AI that streamline workflows,
    empower employees, and strengthen organizational resilience
  • Sharing key insights on implementing AI at scale, focusing on high-impact use cases and cross
    functional enablement for sustainable transformation

CLOSING PANEL DISCUSSION: Strategies for minimising participant burden to ensure on-time enrolment in rare disease research

  • Where are the main hurdles patients face and how can these be removed?
  • Barriers to clinical trial participation from a patient perspective
  • Informed consent and addressing various levels of health literacy in the patient population: how to improve communication
  • Engaging patients and advocacy groups early on in the clinical trial design process
  • Patient reimbursement: how to relieve financial pressures on patients participating in orphan trials

How to optimize cost-efficiency in rare diseases clinical trials

  • Control costs in rare disease clinical trials by tackling complexity and uncertainty head-on
  • Optimize site and country selection to reduce startup delays and unnecessary costs
  • Streamline vendor management with clear oversight and performance-driven partnerships
  • Leverage operational efficiencies (monitoring strategies, data management, patient engagement)
  • Maintain quality and patient focus while optimizing financial sustainability

Exploring GCC clinical research landscape

  • Infrastructure Strengths of the UAE & GCC for Clinical Research
  • UAE’s Precision Medicine and Genomics Ecosystem: A Global Benchmark
  • Why the GCC is Emerging as the Next Global Hub for Clinical Trials